HEADER MEMBRANE PROTEIN/IMMUNE SYSTEM 08-JAN-25 9LFC TITLE CRYO-EM STRUCTURE OF HUMAN BRADYKININ RECEPTOR B1R BOUND TO ANTAGONIST TITLE 2 R715 COMPND MOL_ID: 1; COMPND 2 MOLECULE: B1 BRADYKININ RECEPTOR,KAPPA-TYPE OPIOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: B1R,BK-1 RECEPTOR,K-OR-1,KOR-1; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NANOBODY 6; COMPND 9 CHAIN: C; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: R715; COMPND 13 CHAIN: B; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: PUBCHEM ID 5311397 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BDKRB1, BRADYB1, OPRK1, OPRK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 10 ORGANISM_TAXID: 9844; SOURCE 11 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES; SOURCE 15 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 16 ORGANISM_TAXID: 32630 KEYWDS GPCR, BRADYKININ RECEPTOR, MEMBRANE PROTEIN/IMMUNE SYSTEM, MEMBRANE KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR M.XIA,H.ZHANG REVDAT 1 27-MAY-26 9LFC 0 JRNL AUTH M.XIA,H.ZHANG JRNL TITL CRYO-EM STRUCTURE OF HUMAN BRADYKININ RECEPTOR B1R BOUND TO JRNL TITL 2 ANTAGONIST R715 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, CRYOSPARC, PHENIX, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 232403 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9LFC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 14-JAN-25. REMARK 100 THE DEPOSITION ID IS D_1300054924. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : BRADYKININ RECEPTOR B1R WITH REMARK 245 KAPPA-TYPE OPIOID RECEPTOR ICL3 REMARK 245 IN COMPLEX WITH NB6, R715 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 700.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 TRP A 5 REMARK 465 PRO A 6 REMARK 465 PRO A 7 REMARK 465 LEU A 8 REMARK 465 GLU A 9 REMARK 465 LEU A 10 REMARK 465 GLN A 11 REMARK 465 SER A 12 REMARK 465 SER A 13 REMARK 465 ASN A 14 REMARK 465 GLN A 15 REMARK 465 SER A 16 REMARK 465 GLN A 17 REMARK 465 LEU A 18 REMARK 465 PHE A 19 REMARK 465 PRO A 20 REMARK 465 GLN A 21 REMARK 465 ASN A 22 REMARK 465 ALA A 23 REMARK 465 THR A 24 REMARK 465 ALA A 25 REMARK 465 CYS A 26 REMARK 465 LYS A 328 REMARK 465 GLN A 329 REMARK 465 CYS A 330 REMARK 465 THR A 331 REMARK 465 PRO A 332 REMARK 465 LYS A 333 REMARK 465 SER A 334 REMARK 465 LEU A 335 REMARK 465 ALA A 336 REMARK 465 PRO A 337 REMARK 465 ILE A 338 REMARK 465 SER A 339 REMARK 465 SER A 340 REMARK 465 SER A 341 REMARK 465 MET C -37 REMARK 465 LEU C -36 REMARK 465 LEU C -35 REMARK 465 VAL C -34 REMARK 465 ASN C -33 REMARK 465 GLN C -32 REMARK 465 SER C -31 REMARK 465 HIS C -30 REMARK 465 GLN C -29 REMARK 465 GLY C -28 REMARK 465 PHE C -27 REMARK 465 ASN C -26 REMARK 465 LYS C -25 REMARK 465 GLU C -24 REMARK 465 HIS C -23 REMARK 465 THR C -22 REMARK 465 SER C -21 REMARK 465 LYS C -20 REMARK 465 MET C -19 REMARK 465 VAL C -18 REMARK 465 SER C -17 REMARK 465 ALA C -16 REMARK 465 ILE C -15 REMARK 465 VAL C -14 REMARK 465 LEU C -13 REMARK 465 TYR C -12 REMARK 465 VAL C -11 REMARK 465 LEU C -10 REMARK 465 LEU C -9 REMARK 465 ALA C -8 REMARK 465 ALA C -7 REMARK 465 ALA C -6 REMARK 465 ALA C -5 REMARK 465 HIS C -4 REMARK 465 SER C -3 REMARK 465 ALA C -2 REMARK 465 PHE C -1 REMARK 465 ALA C 0 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 GLY C 11 REMARK 465 GLY C 12 REMARK 465 LEU C 13 REMARK 465 VAL C 14 REMARK 465 GLN C 15 REMARK 465 ALA C 16 REMARK 465 GLY C 17 REMARK 465 GLU C 18 REMARK 465 SER C 19 REMARK 465 ARG C 41 REMARK 465 VAL C 42 REMARK 465 SER C 43 REMARK 465 GLY C 44 REMARK 465 ASN C 45 REMARK 465 GLN C 46 REMARK 465 SER C 86 REMARK 465 LEU C 87 REMARK 465 LYS C 88 REMARK 465 PRO C 89 REMARK 465 GLU C 90 REMARK 465 ASP C 91 REMARK 465 THR C 92 REMARK 465 SER C 122 REMARK 465 SER C 123 REMARK 465 HIS C 124 REMARK 465 HIS C 125 REMARK 465 HIS C 126 REMARK 465 HIS C 127 REMARK 465 HIS C 128 REMARK 465 HIS C 129 REMARK 465 GLU C 130 REMARK 465 PRO C 131 REMARK 465 GLU C 132 REMARK 465 ALA C 133 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 27 CG OD1 OD2 REMARK 470 GLU A 31 CG CD OE1 OE2 REMARK 470 LEU A 35 CG CD1 CD2 REMARK 470 LEU A 52 CG CD1 CD2 REMARK 470 LEU A 56 CG CD1 CD2 REMARK 470 LEU A 60 CG CD1 CD2 REMARK 470 LEU A 63 CG CD1 CD2 REMARK 470 GLU A 73 CG CD OE1 OE2 REMARK 470 ARG A 150 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 183 CG OD1 OD2 REMARK 470 ASN A 185 CG OD1 ND2 REMARK 470 LEU A 275 CG CD1 CD2 REMARK 470 GLN A 279 CG CD OE1 NE2 REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 285 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 317 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 318 CG CD1 CD2 REMARK 470 LEU A 326 CG CD1 CD2 REMARK 470 GLN C 3 CG CD OE1 NE2 REMARK 470 GLN C 5 CG CD OE1 NE2 REMARK 470 GLN C 7 CG CD OE1 NE2 REMARK 470 GLU C 8 CG CD OE1 OE2 REMARK 470 LEU C 20 CG CD1 CD2 REMARK 470 ARG C 21 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 22 CG CD1 CD2 REMARK 470 SER C 27 OG REMARK 470 THR C 29 OG1 CG2 REMARK 470 ARG C 40 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 47 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 48 CG CD OE1 OE2 REMARK 470 LEU C 49 CG CD1 CD2 REMARK 470 SER C 52 OG REMARK 470 ILE C 53 CG1 CG2 CD1 REMARK 470 SER C 58 OG REMARK 470 LYS C 60 CG CD CE NZ REMARK 470 ASP C 63 CG OD1 OD2 REMARK 470 SER C 64 OG REMARK 470 VAL C 65 CG1 CG2 REMARK 470 LYS C 66 CG CD CE NZ REMARK 470 ARG C 68 CG CD NE CZ NH1 NH2 REMARK 470 PHE C 69 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS C 77 CG CD CE NZ REMARK 470 LEU C 82 CG CD1 CD2 REMARK 470 GLN C 83 CG CD OE1 NE2 REMARK 470 MET C 84 CG SD CE REMARK 470 GLU C 107 CG CD OE1 OE2 REMARK 470 GLU C 108 CG CD OE1 OE2 REMARK 470 GLN C 115 CG CD OE1 NE2 REMARK 470 GLN C 118 CG CD OE1 NE2 REMARK 470 THR C 120 OG1 CG2 REMARK 470 VAL C 121 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 29 72.20 51.53 REMARK 500 TRP A 103 107.48 -55.59 REMARK 500 SER B 8 111.45 -6.02 REMARK 500 4J2 B 9 -2.84 175.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 7 SER B 8 -109.01 REMARK 500 SER B 8 4J2 B 9 80.81 REMARK 500 4J2 B 9 ILE B 10 -114.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 3 0.13 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-63044 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF HUMAN BRADYKININ RECEPTOR B1R BOUND TO REMARK 900 ANTAGONIST R715 DBREF 9LFC A 2 231 UNP P46663 BKRB1_HUMAN 2 231 DBREF 9LFC A 232 255 UNP P41145 OPRK_HUMAN 256 279 DBREF 9LFC A 256 341 UNP P46663 BKRB1_HUMAN 256 341 DBREF 9LFC C -37 133 PDB 9LFC 9LFC -37 133 DBREF 9LFC B 1 10 PDB 9LFC 9LFC 1 10 SEQADV 9LFC LYS A 124 UNP P46663 SER 124 ENGINEERED MUTATION SEQADV 9LFC CYS A 132 UNP P46663 SER 132 ENGINEERED MUTATION SEQRES 1 A 340 ALA SER SER TRP PRO PRO LEU GLU LEU GLN SER SER ASN SEQRES 2 A 340 GLN SER GLN LEU PHE PRO GLN ASN ALA THR ALA CYS ASP SEQRES 3 A 340 ASN ALA PRO GLU ALA TRP ASP LEU LEU HIS ARG VAL LEU SEQRES 4 A 340 PRO THR PHE ILE ILE SER ILE CYS PHE PHE GLY LEU LEU SEQRES 5 A 340 GLY ASN LEU PHE VAL LEU LEU VAL PHE LEU LEU PRO ARG SEQRES 6 A 340 ARG GLN LEU ASN VAL ALA GLU ILE TYR LEU ALA ASN LEU SEQRES 7 A 340 ALA ALA SER ASP LEU VAL PHE VAL LEU GLY LEU PRO PHE SEQRES 8 A 340 TRP ALA GLU ASN ILE TRP ASN GLN PHE ASN TRP PRO PHE SEQRES 9 A 340 GLY ALA LEU LEU CYS ARG VAL ILE ASN GLY VAL ILE LYS SEQRES 10 A 340 ALA ASN LEU PHE ILE LYS ILE PHE LEU VAL VAL ALA ILE SEQRES 11 A 340 CYS GLN ASP ARG TYR ARG VAL LEU VAL HIS PRO MET ALA SEQRES 12 A 340 SER ARG ARG GLN GLN ARG ARG ARG GLN ALA ARG VAL THR SEQRES 13 A 340 CYS VAL LEU ILE TRP VAL VAL GLY GLY LEU LEU SER ILE SEQRES 14 A 340 PRO THR PHE LEU LEU ARG SER ILE GLN ALA VAL PRO ASP SEQRES 15 A 340 LEU ASN ILE THR ALA CYS ILE LEU LEU LEU PRO HIS GLU SEQRES 16 A 340 ALA TRP HIS PHE ALA ARG ILE VAL GLU LEU ASN ILE LEU SEQRES 17 A 340 GLY PHE LEU LEU PRO LEU ALA ALA ILE VAL PHE PHE ASN SEQRES 18 A 340 TYR HIS ILE LEU ALA SER LEU ARG THR VAL ARG LEU LEU SEQRES 19 A 340 SER GLY SER ARG GLU LYS ASP ARG ASN LEU ARG ARG ILE SEQRES 20 A 340 THR ARG LEU VAL LEU VAL VAL VAL VAL ALA PHE LEU VAL SEQRES 21 A 340 CYS TRP ALA PRO TYR HIS PHE PHE ALA PHE LEU GLU PHE SEQRES 22 A 340 LEU PHE GLN VAL GLN ALA VAL ARG GLY CYS PHE TRP GLU SEQRES 23 A 340 ASP PHE ILE ASP LEU GLY LEU GLN LEU ALA ASN PHE PHE SEQRES 24 A 340 ALA PHE THR ASN SER SER LEU ASN PRO VAL ILE TYR VAL SEQRES 25 A 340 PHE VAL GLY ARG LEU PHE ARG THR LYS VAL TRP GLU LEU SEQRES 26 A 340 TYR LYS GLN CYS THR PRO LYS SER LEU ALA PRO ILE SER SEQRES 27 A 340 SER SER SEQRES 1 C 171 MET LEU LEU VAL ASN GLN SER HIS GLN GLY PHE ASN LYS SEQRES 2 C 171 GLU HIS THR SER LYS MET VAL SER ALA ILE VAL LEU TYR SEQRES 3 C 171 VAL LEU LEU ALA ALA ALA ALA HIS SER ALA PHE ALA MET SEQRES 4 C 171 ALA GLN VAL GLN LEU GLN GLU SER GLY GLY GLY LEU VAL SEQRES 5 C 171 GLN ALA GLY GLU SER LEU ARG LEU SER CYS ALA ALA SER SEQRES 6 C 171 GLY THR ILE PHE ARG LEU TYR ASP MET GLY TRP TYR ARG SEQRES 7 C 171 ARG VAL SER GLY ASN GLN ARG GLU LEU VAL ALA SER ILE SEQRES 8 C 171 THR SER GLY GLY SER THR LYS TYR GLY ASP SER VAL LYS SEQRES 9 C 171 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN THR SEQRES 10 C 171 VAL TYR LEU GLN MET SER SER LEU LYS PRO GLU ASP THR SEQRES 11 C 171 ALA VAL TYR TYR CYS ASN ALA GLU TYR ARG THR GLY ILE SEQRES 12 C 171 TRP GLU GLU LEU LEU ASP GLY TRP GLY GLN GLY THR GLN SEQRES 13 C 171 VAL THR VAL SER SER HIS HIS HIS HIS HIS HIS GLU PRO SEQRES 14 C 171 GLU ALA SEQRES 1 B 10 ACE LYS ARG PRO PRO GLY PHE SER 4J2 ILE HET ACE B 1 3 HET 4J2 B 9 15 HETNAM ACE ACETYL GROUP HETNAM 4J2 (2R)-2-AMINO-3-(NAPHTHALEN-2-YL)PROPANOIC ACID FORMUL 3 ACE C2 H4 O FORMUL 3 4J2 C13 H13 N O2 HELIX 1 AA1 ALA A 29 LEU A 64 1 36 HELIX 2 AA2 ASN A 70 GLY A 89 1 20 HELIX 3 AA3 GLY A 89 ASN A 99 1 11 HELIX 4 AA4 PHE A 105 VAL A 140 1 36 HELIX 5 AA5 ARG A 146 LEU A 174 1 29 HELIX 6 AA6 HIS A 195 PHE A 211 1 17 HELIX 7 AA7 PHE A 211 THR A 231 1 21 HELIX 8 AA8 SER A 238 VAL A 278 1 41 HELIX 9 AA9 GLY A 283 VAL A 315 1 33 HELIX 10 AB1 GLY A 316 TYR A 327 1 12 SHEET 1 AA1 2 ARG A 176 VAL A 181 0 SHEET 2 AA1 2 ILE A 186 LEU A 191 -1 O ILE A 186 N VAL A 181 SHEET 1 AA2 4 VAL C 4 SER C 9 0 SHEET 2 AA2 4 ARG C 21 GLY C 28 -1 O SER C 23 N SER C 9 SHEET 3 AA2 4 THR C 79 GLN C 83 -1 O LEU C 82 N LEU C 22 SHEET 4 AA2 4 THR C 70 ASP C 74 -1 N SER C 72 O TYR C 81 SHEET 1 AA3 5 THR C 59 TYR C 61 0 SHEET 2 AA3 5 LEU C 49 THR C 54 -1 N SER C 52 O LYS C 60 SHEET 3 AA3 5 ARG C 32 TYR C 39 -1 N TRP C 38 O ALA C 51 SHEET 4 AA3 5 VAL C 94 ARG C 102 -1 O GLU C 100 N ASP C 35 SHEET 5 AA3 5 LEU C 110 GLY C 112 -1 O LEU C 110 N TYR C 101 SHEET 1 AA4 5 THR C 59 TYR C 61 0 SHEET 2 AA4 5 LEU C 49 THR C 54 -1 N SER C 52 O LYS C 60 SHEET 3 AA4 5 ARG C 32 TYR C 39 -1 N TRP C 38 O ALA C 51 SHEET 4 AA4 5 VAL C 94 ARG C 102 -1 O GLU C 100 N ASP C 35 SHEET 5 AA4 5 THR C 117 GLN C 118 -1 O THR C 117 N TYR C 95 SSBOND 1 CYS A 110 CYS A 189 1555 1555 2.03 SSBOND 2 CYS C 24 CYS C 97 1555 1555 2.03 LINK C ACE B 1 N LYS B 2 1555 1555 1.33 LINK C SER B 8 N 4J2 B 9 1555 1555 1.33 LINK C 4J2 B 9 N ILE B 10 1555 1555 1.34 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 657 1276 CONECT 1276 657 CONECT 2475 2880 CONECT 2880 2475 CONECT 3054 3055 3056 3057 CONECT 3055 3054 CONECT 3056 3054 CONECT 3057 3054 CONECT 3108 3112 CONECT 3112 3108 3113 CONECT 3113 3112 3114 3125 CONECT 3114 3113 3115 CONECT 3115 3114 3116 3117 CONECT 3116 3115 3118 CONECT 3117 3115 3122 CONECT 3118 3116 3119 CONECT 3119 3118 3120 3122 CONECT 3120 3119 3121 CONECT 3121 3120 3124 CONECT 3122 3117 3119 3123 CONECT 3123 3122 3124 CONECT 3124 3121 3123 CONECT 3125 3113 3126 3127 CONECT 3126 3125 CONECT 3127 3125 MASTER 330 0 2 10 16 0 0 6 3133 3 25 42 END